The temporomandibular joint, or TMJ, is the hinge where your jaw meets your skull, and it is one of the most used joints in the body. When it clicks, locks, or aches, eating, talking, and even sleeping can become painful, and jaw complaints send many Honolulu residents searching for a regenerative option. Platelet-rich plasma (PRP) is increasingly offered for TMJ problems, and unlike some other joints, the 2026 evidence here is genuinely more supportive, with several new systematic reviews. This article reads that evidence honestly and explains what a responsible jaw evaluation should include.
31
studies and 1,718 patients in a 2026 systematic review and meta-analysis of PRP, arthrocentesis, and conservative care for TMJ disorders
6 months
timepoint at which PRP was significantly superior for TMJ pain in the 2026 meta-analysis
100% vs 68.8%
accurate intra-articular placement with ultrasound-guided versus palpation-guided PRP injection in a 2026 double-blind trial
The jaw joint is small, complex, and does more work than almost any other joint in the body, chewing, talking, and swallowing thousands of times a day. Pain in the area can come from the joint itself, from the disc inside it, from the muscles that move the jaw, or from teeth grinding and clenching, often at night. Those causes respond differently to treatment, which is why a vague jaw injection without a diagnosis is rarely a good idea.
A systematic review and meta-analysis published in June 2026 pooled 31 studies and 1,718 patients comparing arthrocentesis, PRP, and conservative therapy for TMJ disorders. It found that arthrocentesis, a small joint washout, gave a small short-term benefit in mouth opening at one week. But PRP was significantly superior for pain at six months. That pattern, modest early differences and a stronger longer-term result, is consistent with what PRP shows in other joints.
“In a 2026 systematic review and meta-analysis of 31 studies and 1,718 patients, PRP was significantly superior for pain reduction at six months compared with arthrocentesis and conservative care, while arthrocentesis offered only a small short-term benefit in mouth opening at one week.”
The TMJ is small and sits close to nerves and blood vessels, so precise placement is not optional. A double-blind randomized trial published in January 2026 compared ultrasound-guided and palpation-guided PRP injection in 64 patients. Image guidance achieved accurate placement inside the joint in 100 percent of injections versus 68.8 percent for palpation-guided delivery, with significantly better outcomes for both pain and mouth opening. In practice, that means the imaging and skill a clinic uses matter as much as the PRP itself.
“In a 2026 double-blind randomized trial of 64 patients, ultrasound-guided PRP injection for TMJ disorders achieved accurate intra-articular placement in 100 percent of cases versus 68.8 percent for palpation-guided injection, with significantly better pain and mouth-opening outcomes.”
The 2026 evidence is encouraging, but it is not unanimous. A 2026 systematic review in CRANIO of PRP without arthrocentesis in TMJ degenerative disease found that PRP appears safe and potentially effective, while explicitly calling for more high-quality trials. Results vary by comparator and time point, some of the benefit of any injection is the injection itself, and preparation standards differ between clinics. The evidence supports PRP as a reasonable second-line option with realistic expectations, not as a guaranteed fix for every click or ache.
Because jaw pain has so many possible sources, an evaluation should separate a joint problem from a disc problem, a muscle problem, or a dental issue before any injection is discussed. That means a careful history, including questions about clenching and grinding, a physical exam of how the jaw opens and moves, and sometimes imaging. Conservative care, including soft-food phases, a night guard for grinding, jaw physical therapy, and attention to sleep and stress, is usually the first step. PRP, when it is considered, fits into a plan that includes those basics, not one that skips them.
For TMJ disorders, the 2026 evidence gives PRP a real but careful role: it appears safe, it outperformed arthrocentesis and conservative care for pain at six months in the largest recent meta-analysis, and image-guided delivery matters. It is not a substitute for a diagnosis, a night guard, or jaw physical therapy. The defensible plan is a proper evaluation first, conservative care second, and an injection decision made on the specific findings in your jaw.
A note from the clinic
At Aloha Stem Cell in Honolulu we evaluate jaw pain the way we evaluate every joint: a careful history, a physical exam, imaging when it is indicated, and an honest read on whether an injection is supported by the evidence for your specific problem. If PRP looks right for your TMJ, we will say so and explain why; if a night guard, jaw therapy, or a dental or surgical specialist is the better answer, we will say that instead. Call (808) 593-2525 or book a consultation.
Our team is happy to listen to your story, answer your questions, and help you decide whether a consultation makes sense. There is no pressure and no obligation.
Keep reading
Red light therapy, or photobiomodulation, is one of the most popular wellness treatments for achy knees in Honolulu. Here is what the 2025-2026 evidence really shows, read honestly.
In September 2026 the first human trial of an edited stem cell therapy for osteoporosis reported a roughly 94 percent drop in fragility fractures. Here is what the study actually showed, and what it does not mean yet.
In 2026 the therapy closest to an FDA-approved stem cell product for arthritis cleared three major milestones: a positive Japan Phase 3 trial, an FDA agreement on a single pivotal U.S. study, and the first U.S. patient treated. Here is what the milestones really mean, and what they do not.
Book a consultation
Pick a time that works for you and our team will confirm your consultation. Questions first? Call us anytime at (808) 593-2525.